Stock Market Reviews

Read and share opinions on MDT (Medtronic plc) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Bearish Options Activity Emerges on Medtronic plc (MDT) Despite Long-Term Growth Outlook
  Dec 30, 2025
• MDT vs. ESLOY: Which Stock Is the Better Value Option?
  Dec 22, 2025
• 4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
  Dec 22, 2025
• Stifel Maintains Hold on Medtronic (MDT) After FDA Approves HUGO System
  Dec 22, 2025
• Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Stock Could Move In The Opposite Direction?
  Dec 20, 2025
• Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
  Dec 19, 2025

MDT News

• UnitedHealth Works Toward Recovery and 4 More Healthcare Themes to Watch in 2026
  Much in the new year depends on the fundamentals, which remain as complicated as ever. Watch these stocks.
  Dec 29, 2025
• 5 Healthcare Themes for Investors to Watch in 2026
  Much in the new year depends on the fundamentals, which remain as complicated as ever. Watch these stocks.
  Dec 28, 2025
• Have $2,000? 3 Top Robotics Stocks to Buy and Hold for at Least a Decade
  These top robotics stocks are compelling for different reasons.
  Dec 27, 2025
• Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever
  If you are looking for high yields, this drug maker and this device maker are both worth a deep dive today.
  Dec 24, 2025
• Should You Hold On To BSX Stock Despite Its Premium Valuation?
  Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.
  Dec 23, 2025
• The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences
  Cardinal Health leads Zacks' list of large-cap MedTech stocks as AI adoption, robotics and rising procedure volumes set up continued gains in 2026.
  Dec 23, 2025
• 2026 Rate Cuts Coming as Inflation Drops: 5 Quality Dividend Stocks to Buy Now
  Growth and income investors can buy these five top dividend stocks now, tomorrow, next week, or next year and hold for the long term.
  Dec 23, 2025
• Medtronic’s diabetes spinoff MiniMed files for IPO
  MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.
  Dec 22, 2025
• MDT vs. ESLOY: Which Stock Is the Better Value Option?
  MDT vs. ESLOY: Which Stock Is the Better Value Option?
  Dec 22, 2025
• 4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
  Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.
  Dec 22, 2025
• Is It Too Late To Consider Medtronic After Its Strong 2025 Share Price Rally?
  If you are wondering whether Medtronic at around $98 is still a smart buy or if most of the upside is already priced in, this article will walk through what the market might be missing. The stock is up 22.9% year to date and 25.2% over the last year, even after a recent 2.5% pullback over the past month. This suggests sentiment has improved but is still a bit cautious after a flat 5 year return of -1.2%. That backdrop comes as Medtronic keeps leaning into high growth areas such as robotic...
  Dec 22, 2025
• Stifel Maintains Hold on Medtronic (MDT) After FDA Approves HUGO System
  Medtronic plc (NYSE:MDT) is one of the best healthcare AI stocks to buy now. On December 4, Stifel reaffirmed its Hold rating on Medtronic plc (NYSE:MDT), along with a $105 price target. This action came soon after the FDA granted regulatory approval to Medtronic’s HUGO robotic-assisted surgery (RAS) system. Stifel described the HUGO approval as […]
  Dec 22, 2025
• Stocks to Watch Monday: Tesla, Rocket Lab, Clearwater Analytics
  ↗️ Tesla (TSLA): The electric-vehicle maker won a yearslong legal battle in Delaware over a record-breaking 2018 pay package for Elon Musk. Shares rose 1.5% in premarket trading. 🔎 Medtronic (MDT): MiniMed, a subsidiary that makes medical technology for diabetes patients, filed to go public.
  Dec 22, 2025
• Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Stock Could Move In The Opposite Direction?
  Medtronic's (NYSE:MDT) stock up by 3.7% over the past three months. However, its weak financial performance indicators...
  Dec 20, 2025
• 3 Top Dividend Stocks I Plan to Buy Hand Over Fist in 2026
  These companies should have no trouble continuing to increase their dividends in 2026.
  Dec 20, 2025
• Top Research Reports for NVIDIA, Netflix & Merck
  New research highlights NVIDIA's AI-driven growth, Netflix's ad-tier momentum and Merck's pipeline progress, while microcaps also make the cut.
  Dec 19, 2025
• Medtronic Brought Darüşşafaka Students Together With Health Technologies
  Medtronic Türkiye hosted 110 students from Darüşşafaka at an event organized with the aim of "awakening curiosity and inspiring future careers in healthcare technologies." NORTHAMPTON, MA / ACCESS Newswire / December 19, 2025 / With its ...
  Dec 19, 2025
• Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
  Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of newly issued common stock. The separation is expected to be completed through a series of capital markets transactions, with a preferred path of an IPO and subsequent spl
  Dec 19, 2025
• Medtronic’s Diabetes Management Business MiniMed Files for IPO
  The Northridge, California-based company had a net loss of $21 million on revenue of $1.5 billion for the six months ended October 24, compared with a net loss of $23 million on revenue of $1.3 billion in the corresponding period a year earlier, according to its filing Friday with the US Securities and Exchange Commission. The filing positions the company to join a busy slate of possible debuts in the first months of 2026.
  Dec 19, 2025
• Medtronic Spin-Off MiniMed Files for IPO
  MiniMed Group, a subsidiary of Medtronic is looking to spin itself off as an independent company via an initial public offering. The company, which makes medical technology for diabetes patients, filed to go public with the Securities and Exchange Commission on Friday. “Our goal is to accelerate the impact we can have as an independent company focused exclusively on helping insulin-dependent people with diabetes experience more predictable control, greater freedom, and better days while achieving strong outcomes.”
  Dec 19, 2025
• Why Is Medtronic (MDT) Down 2% Since Last Earnings Report?
  Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
  Dec 18, 2025
• Record-breaking CIIE 2025 Achievements Signal Global Momentum
  SHANGHAI, December 18, 2025--The eighth China International Import Expo (CIIE) has concluded with record results, underscoring its growing global influence and China’s commitment to openness. Over six days, the expo welcomed 922,000 visits—an all-time high and an 8.2% increase from last year. Intended one-year purchase deals reached $83.49 billion, up 4.4% year-on-year. With 4,108 exhibitors from 138 countries and regions in attendance—the broadest participation to date—this turnout highlighted
  Dec 18, 2025
• Boston Scientific's Global Expansion: What's Behind the Growth?
  BSX expands globally with R&D, AI-driven manufacturing and Emerging Markets, aiming for $1B+ revenues in China in 2025.
  Dec 18, 2025
• Blood Glucose Monitor Market Set to Reach USD 25.4 Billion by 2030 with a CAGR of 9.1%
  The global blood glucose monitor market is set to expand from USD 16.5 billion in 2025 to USD 25.4 billion by 2030, growing at a CAGR of 9.1%. This growth is fueled by the increasing prevalence of diabetes, a rising geriatric population, and enhanced self-monitoring awareness. Technological advancements in continuous glucose monitoring (CGM), smartphone integration, and AI data analytics have boosted accuracy and patient engagement. The self-monitoring blood glucose systems segment leads in mark
  Dec 17, 2025
• Sector Update: Health Care Stocks Retreat Late Afternoon
  Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index falling 1.6% and
  Dec 16, 2025
• PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors
  Appointment Enhances PolyPid’s Strategic, Commercial and Transaction Capabilities Ahead of D-PLEX₁₀₀ New Drug Application SubmissionPETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. “Brooke’s appointment marks an exciting and pivotal moment for P
  Dec 16, 2025
• Build a Stronger 2026 Portfolio With These 5 Dividend Aristocrats
  ATO, MDT, PEP, CAT and SPGI stand out as dividend aristocrats for 2026, offering decades of hikes, solid yields and defensive income.
  Dec 15, 2025
• Will a Robot Help Perform Your Next Surgery?
  FDA clears the Medtronic Hugo™ robotic-assisted surgery system for urologic procedures. NORTHAMPTON, MA / ACCESS Newswire / December 15, 2025 / James Choate-Deeds and his wife Caryn held hands and braced themselves for the test results. "It's ...
  Dec 15, 2025
• 3 Dividend Stocks to Hold for the Next 10 Years
  If you are looking for dividend stocks that you can buy and hold, consider UPS, General Mills, and Medtronic.
  Dec 14, 2025
• This Dividend Stock Just Hit a Major Milestone. Time to Buy?
  The company is closing out a strong year on a good note.
  Dec 14, 2025
• Did FDA-Approved Hugo Robot and New Diabetes Tech Just Shift Medtronic's (MDT) Investment Narrative?
  In early December 2025, Medtronic’s board approved a US$0.71 per-share cash dividend for the third quarter of fiscal 2026, payable on January 16, 2026, and the company secured FDA clearance for its Hugo robotic-assisted surgery system in urologic procedures while launching its MiniMed 780G system with Abbott’s Instinct sensor across the U.S. Together, these developments highlight how Medtronic is pairing a long-running dividend growth record with fresh momentum in robotics and diabetes...
  Dec 12, 2025
• Assessing Medtronic’s (MDT) Valuation After Its Steady 24% Year-to-Date Share Price Climb
  Medtronic (MDT) has quietly outperformed the broader healthcare space over the past year, and that steady climb is getting investors to revisit whether this long standing medical device leader still offers reasonable upside. See our latest analysis for Medtronic. Despite a soft patch in the last week, Medtronic’s roughly 24 percent year to date share price return and solid one year total shareholder return near 25 percent point to steady, not euphoric, momentum as investors warm to its...
  Dec 12, 2025
• Can Intuitive Surgical Weather GLP-1 Drag on Bariatric Surgery?
  Intuitive Surgical grapples with a GLP-1-driven bariatric slump but leans on strong general surgery gains and rising da Vinci 5 adoption.
  Dec 11, 2025
• Boston Scientific Sustains Momentum in the PFA Market: What's Next?
  BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.
  Dec 11, 2025
• Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors
  LAGUNA HILLS, Calif., December 11, 2025--Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmon has been appointed to its Board of Directors. Mr. Salmon will also serve on the Company’s Audit Committee and Compensation Committee.
  Dec 11, 2025
• Berlin Heals Welcomes Rob ten Hoedt as New Chairman of the Board
  Berlin Heals Holding AG (Zug, Switzerland) is pleased to announce the appointment of Rob ten Hoedt as the new Chairman of the Board of Directors.
  Dec 10, 2025
• How Recent Developments Are Shaping the Medtronic Investment Story
  Medtronic's fair value estimate has nudged higher to $111.05 from $109.82 as analysts grow more confident that the company can sustain mid single digit plus organic growth. A slightly lower discount rate and largely unchanged revenue growth outlook reflect a market that is increasingly willing to recognize the durability of Medtronic's cash flow narrative, while still acknowledging execution risks. Read on to see how this evolving Wall Street debate may help investors stay informed about...
  Dec 10, 2025
• Medtronic changes investor relations leadership ahead of diabetes spinout
  Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned new diabetes company.
  Dec 9, 2025
• ISRG Stock Forms Golden Crossover: Will the Uptrend Continue?
  Intuitive Surgical's golden crossover arrives amid surging procedures and rapid dV5 adoption, raising the stakes for its bullish momentum.
  Dec 8, 2025
• Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
  Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization of AVIM Therapy for treatment of uncontrolled hypertension in patients indicated for a pacemaker NEW HOPE, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships,
  Dec 8, 2025
• TIFIN Appoints Andrew Dahlinghaus as Chief Operating Officer
  TIFIN today announced that Andrew Dahlinghaus will join as Chief Operating Officer. He brings more than 25 years of leadership across legal, regulatory, and operational disciplines in technology-driven, highly regulated industries. In this role, he will report directly to Founder and CEO Dr. Vinay Nair and will lead TIFIN's next phase of execution across its AI platform.
  Dec 8, 2025
• 3 No-Brainer Dividend Stocks to Buy Right Now
  These companies have terrific records of increasing their dividends.
  Dec 8, 2025
• Is Medtronic Still Attractively Priced After Its Strong 2025 Share Price Rally?
  If you are wondering whether Medtronic is still a solid buy at around $101 a share, or if the easy money has already been made, you are in the right place to unpack what the current price really implies. Despite slipping 3.8% over the last week, the stock is still up 12.1% over the past month, 26.4% year to date, and 24.6% over the last year, which has put valuation firmly back in the spotlight. Much of this renewed interest has come as investors refocus on high quality, cash generative...
  Dec 7, 2025
• Forget Medtronic, Buy This Healthcare Stock Instead
  That is, if you can handle more volatility.
  Dec 7, 2025
• MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System
  Medtronic gains from the FDA clearance of its Hugo RAS system, expanding U.S. access to robotic-assisted urologic surgery.
  Dec 5, 2025
• MDT or ESLOY: Which Is the Better Value Stock Right Now?
  MDT vs. ESLOY: Which Stock Is the Better Value Option?
  Dec 5, 2025
• Medtronic (MDT) Upgraded to Buy: Here's Why
  Medtronic (MDT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
  Dec 5, 2025
• Should You Hold STERIS Stock in Your Portfolio for Now?
  STE posts solid AST and Healthcare growth, but currency swings and macro pressures pose rising challenges.
  Dec 4, 2025
• Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions
  HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.
  Dec 4, 2025
• Margins Face Tariff Pressure: Is ISRG's Profitability at Risk?
  Intuitive Surgical's strong growth contrasts with tariff-driven margin pressure, raising questions about its ability to hold gross margins near 67%.
  Dec 4, 2025
• IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge?
  IDXX surges 75.6% YTD as strong CAG Diagnostics momentum and high-demand software solutions fuel growth.
  Dec 4, 2025
• Medtronic’s Hugo surgical robot earns FDA clearance
  With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic programs, a company executive said.
  Dec 4, 2025
• Medtronic announces cash dividend for third quarter of fiscal year 2026
  The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 48 consecutive years. The dividend is payable on January 16, 2026,
  Dec 4, 2025
• Prediction: 1 Healthcare Giant Set to Soar in 2026
  Things are finally looking up for the company.
  Dec 4, 2025
• The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock
  Medtronic begins the U.S. rollout of MiniMed 780G with Abbott's Instinct sensor, advancing diabetes care.
  Dec 3, 2025
• Should You Continue to Hold RMD Stock in Your Portfolio?
  Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.
  Dec 3, 2025
• TMO Stock Benefits From New Bioprocess Design Center in Asia
  Thermo Fisher expands its Bioprocess Design Centers across Asia, boosting biomanufacturing speed, efficiency and regional innovation.
  Dec 3, 2025
• Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
  Medtronic (NYSE: MDT), a global leader in surgical innovation, today announced the U.S. Food and Drug Administration (FDA) has cleared the Hugo™ robotic-assisted surgery (RAS) system for use in urologic surgical procedures. The Hugo RAS system's clearance brings a versatile robotic-assisted platform to U.S. surgeons and health systems seeking to expand soft-tissue robotic surgery programs and access to minimally invasive care.
  Dec 3, 2025
• Should You Continue to Hold LH Stock in Your Portfolio?
  Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.
  Dec 2, 2025
• We Like Medtronic's (NYSE:MDT) Earnings For More Than Just Statutory Profit
  Shareholders appeared to be happy with Medtronic plc's ( NYSE:MDT ) solid earnings report last week. Looking deeper at...
  Dec 2, 2025
• Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
  Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed™ systems. Following U.S. FDA clearance of the system earlier this year to enable integration with the Instinct sensor, the system is now shipping to customers across the U.S., marking a major milestone in diabetes technology and delivering a smart, seamless way to mana
  Dec 2, 2025
• Healthcare Robotics Research Report 2025: Market to Reach $15.35 Billion by 2030, Driven by Aging Populations and Rising Demand for Minimally Invasive Surgical Solutions
  The healthcare robotics market is driven by advancements in AI, demand for precise surgeries, and the aging population. Opportunities lie in tele-robotics and remote care, extending services to underserved areas. Key players include Intuitive Surgical and Medtronic, with applications in surgery and rehabilitation. Healthcare Robotics Market Healthcare Robotics Market Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Healthcare Robotics Market - Global Industry Size, Share, Trends, Opportunity, and
  Dec 2, 2025
• HSIC Stock Benefits From Expanded Partnership With vVARDIS
  Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.
  Dec 2, 2025
• Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.
  Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion’s commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a heal
  Dec 2, 2025
• mHealth Market Growth Opportunities and Investment Prospects 2025-2030, Featuring Medtronic, Apple, Samsung, Google, Philips and More
  The mHealth market is poised for growth driven by smartphone adoption and rising chronic conditions, promoting remote monitoring and patient-centric care. Challenges include data security concerns. Integrating AI/ML offers personalized health insights. mHealth Market mHealth Market Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "mHealth Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering. The Global mHealth Marke
  Dec 2, 2025
• HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch
  HSIC gains momentum as Henry Schein One rolls out AI-powered dental workflows unveiled at the Greater New York Dental Meeting.
  Dec 1, 2025
• 3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio
  If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.
  Nov 30, 2025
• Barclays Adjusts Medtronic (MDT) Forecast After Encouraging Earnings Report
  Medtronic plc (NYSE:MDT) is included among the 15 Best Boring Dividend Stocks to Buy. On November 20, Barclays raised its price targe⁠t on Medtronic plc (NYSE:MDT) to $111 from $109 while maintaining an Overweight rating‌,⁠ following a‍ strong⁠ quarter that exceeded expectations an‌d prompted the fi‌rm to increase its estimates, as reported by The Fly. […]
  Nov 30, 2025
• Medtronic (MDT) Price Target Raised as PFA Technology Drives Q2 Revenue Gains
  Medtronic plc (NYSE:MDT) ranks among the best slow growth stocks to invest in. Truist Securities increased its price target for Medtronic plc (NYSE:MDT) to $110 from $103 on November 20, while maintaining a Hold rating on the company’s shares. The gain comes after Medtronic’s fiscal second-quarter results, which revealed revenue growth led by the company’s […]
  Nov 29, 2025
• Upbeat Guidance and M&A Focus Could Be a Game Changer for Medtronic (MDT)
  Medtronic reported strong second-quarter results and raised its revenue and earnings guidance for the coming quarters and fiscal years, with management highlighting a renewed focus on tuck-in acquisitions in higher-growth cardiology and neuroscience segments. The company’s emphasis on investments in near- or on-market technologies, alongside upward guidance revisions, signals confidence in ongoing innovation and execution across its core businesses. We’ll examine how this improved outlook...
  Nov 28, 2025
• Xinhua Silk Road: Shanghai's Minhang District showcases industrial strength at CIIE
  During the recent China International Import Expo (CIIE), the reporter delivered on-camera coverage to offer an interpretive guide to the event.
  Nov 28, 2025
• How Is Medtronic's Stock Performance Compared to Other Medical Devices Stocks?
  Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.
  Nov 28, 2025
• Middle East & Africa Home Healthcare Market Analysis Report 2025 Featuring Fresenius Medical, Manzil Healthcare Services, Dallah Healthcare, and Medtronic
  The Middle East & Africa home healthcare market is growing rapidly, driven by rising demand for home-based medical care. Key opportunities include expansion in the services segment, leveraging the market's CAGR of 8.1% from 2019 to 2024, and addressing competitive pressures to capture market share.Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Home Healthcare in Middle East & Africa" report has been added to ResearchAndMarkets.com's offering.Home Healthcare in Middle East & Africa industry profi
  Nov 27, 2025
• Medtronic (MDT) Valuation: Assessing Potential After Raised Outlook and Strong Quarterly Growth
  Medtronic (MDT) gave investors something to talk about after reporting higher sales and profits compared to last year, and raising its outlook for both revenue and earnings. See our latest analysis for Medtronic. Medtronic’s upbeat outlook has added fuel to a rally that’s been building for much of this year, with the stock’s share price climbing nearly 31% year-to-date and posting a robust 11.6% 1-month gain. Strong quarterly results and plans for strategic acquisitions in high-growth therapy...
  Nov 27, 2025
• CMS covers cardiac ablation in ambulatory surgery centers
  Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.
  Nov 26, 2025
• Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board
  Restore Medical Ltd., a privately held medical device company developing a novel transcatheter therapy for heart failure, today announced the appointment of Chris Cleary, former Senior Vice President of Corporate Development at Medtronic, as Chairman of its Board of Directors.
  Nov 26, 2025
• Pediatric Interventional Cardiology Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue
  The Pediatric Interventional Cardiology Market is poised for significant growth, projected to rise from USD 2.42 billion in 2024 to USD 4.34 billion by 2033, exhibiting a 6.68% CAGR. This expansion is driven by the increasing prevalence of congenital heart defects such as VSD, PDA, and ASD in children. The advent of advanced medical devices and the shift towards non-invasive treatments also contribute to market growth. The U.S. stands out as a key player due to rising infant cardiac abnormalitie
  Nov 26, 2025
• Agilent Q4 Earnings Match Estimates, Revenues Up Y/Y, Shares Fall
  A report higher Q4 revenues and lifts its 2026 outlook, yet the stock slips as margins narrow across key business segments.
  Nov 25, 2025
• Indian MedTech Company Makes a Global Mark at PCR London Valves 2025
  Underscoring India's rising influence in global cardiovascular innovation, Meril Life Sciences presented the one-year outcomes from the pivotal LANDMARK Randomized Controlled Trial (RCT) during the Late-Breaking Trial sessions at PCR London Valves 2025, one of the world's most respected structural heart conferences. This milestone marks a significant moment for Indian MedTech, as the indigenous, balloon-expandable Myval THV series is directly compared with leading international transcatheter val
  Nov 25, 2025
• How the Narrative Around Medtronic Is Shifting With Analyst Upgrades and New Product Wins
  Medtronic stock has recently seen its fair value price target raised to $109.82 per share, up from $101.13. This change reflects improved analyst sentiment. The upward revision, combined with a slightly lower discount rate, is largely attributed to the company's robust revenue growth projections and continued operational strength. Stay tuned to discover the key drivers behind these changes and how you can keep up with the evolving narrative around Medtronic’s outlook. Analyst Price Targets...
  Nov 25, 2025
• Relative Strength Soars On Medtronic Stock. Here's How To Get Bullish
  Medtronic stock jumped 2% on Monday as it broke out to a 52-week high and is showing signs of strong accumulation. Medtronic stock recently received an RS Rating upgrade from 67 to 82 making it a great stock to consider for a bullish option trade. A bull call spread involves buying a call and then selling a further out-of-the-money call.
  Nov 25, 2025
• ISRG vs. MDT: A High-Tech Robotics Faceoff in the Race for Leadership
  Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.
  Nov 24, 2025
• Medical Precision Parts Research Report 2025: A $22.42 Bn by 2030, Driven by Automation-Driven Demand for Precision Fluidic Components, Advanced Surface Engineering for Biocompatibility & Anti-Fouling
  The global Medical Precision Parts Market is projected to grow at a CAGR of 5.78% from 2024-2030. Driven by lab automation, precision fluidic components like micro-valves and pipetting heads advance personalized medicine. Advanced engineering boosts biocompatibility and anti-fouling, exemplified by Medtronic implants. CNC-machined parts lead with 28% market share, while metals, particularly titanium and stainless steel, drive demand in orthopedic implants. North America dominates due to advanced
  Nov 24, 2025
• Neonatal Intensive Care Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
  The global neonatal intensive care market is forecasted to grow from $3.68 billion in 2024 to $6.27 billion by 2033, at a CAGR of 6.10%. Neonatal Intensive Care (NIC) focuses on critically ill newborns, particularly premature or congenital-condition babies. The rise in medical technology boosts survival rates, increasing NICU demand. Key players like Masimo Corporation, 3M Company, Medtronic PLC, and others are advancing in this life-saving area. Recent innovations, sustainability efforts, and s
  Nov 24, 2025
• Respiratory Care Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
  The respiratory care devices market is projected to grow from $24.16 billion in 2024 to $49.19 billion by 2033, at a CAGR of 8.22%. The rise is fueled by increasing cases of respiratory diseases such as asthma, COPD, and sleep apnea. Key devices include nebulizers, inhalers, CPAP machines, and ventilators, crucial for therapy and patient monitoring. Top players like Medtronic, Philips, GE Healthcare, and others are driving innovation. Sustainability efforts are notable among companies like Baxte
  Nov 24, 2025
• BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality
  SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces the appointment of Farhan Shahab as Vice President of Quality. Mr. Shahab brings over 25 years of experience to BioCardia in similar executive roles. Mr. Shahab joins BioCardia from Welldoc (a digital health company focused on chronic disease management), where he served as Vice P
  Nov 24, 2025
• Which 'Dividend Prince' Will Become The Next King In 2 Years?
  Medtronic is nearing a crowning achievement.
  Nov 24, 2025
• This Medtech Giant's Stock Is Soaring. Should You Buy It Ahead of 2026?
  Medtronic is proving that it's a reliable company to invest in.
  Nov 24, 2025
• Defibrillator Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
  The global defibrillator market is forecasted to expand significantly, increasing from US$ 13.74 billion in 2024 to US$ 25.80 billion by 2033, with a steady CAGR of 7.25%. Key drivers include the proliferation of public access defibrillators, expanded ambulance services, and a surge in cardiac ailments. Defibrillators like AEDs and manual devices remain crucial in enhancing survival rates during cardiac arrest emergencies. Top players such as Medtronic, Boston Scientific, and Philips are pivotal
  Nov 24, 2025
• What Are the Best Healthcare Stocks to Buy Now? I Think It's Intuitive Surgical (ISRG) -- or, to Play It Safer, Medtronic (MDT)
  Robotic surgery is a hot field, with new entrants coming.
  Nov 23, 2025
• Medtronic (MDT)’s CEO “is One of the Finest People,” Says Jim Cramer
  We recently published 13 Stocks That Crossed Jim Cramer’s Radar. Medtronic plc (NYSE:MDT) is one of the stocks Jim Cramer discussed. Medtronic plc (NYSE:MDT) is a medical technology company that makes and sells devices for cardiovascular, neuroscience, and surgical applications. Cramer has discussed the firm on a handful of occasions in 2025. One such discussion […]
  Nov 21, 2025
• Is Medtronic Fairly Priced After Strong 24% Rally and Innovation Headlines in 2025?
  Ever wondered if Medtronic could be a hidden gem in today’s market? Let’s break down what’s really going on with its stock value and what that might mean for potential investors like you. Medtronic’s share price has climbed 3.3% in the last week and is up a notable 23.8% year-to-date, suggesting either confidence in its long-term prospects or changing attitudes around risk in the healthcare sector. News has recently highlighted Medtronic’s focus on innovation, including partnerships and new...
  Nov 21, 2025
• Surgical Stapling Devices Market Analysis Report 2025: Disposable Surgical Stapling Devices Lead Expansion Amid Rising Demand for Minimally Invasive Procedures - Global Forecast to 2029
  The global surgical stapling devices market, valued at $5.23 billion in 2023, is anticipated to grow to $8.32 billion by 2029, with a CAGR of approximately 8%. This growth is propelled by the rising demand for minimally invasive procedures and increased healthcare investments, especially in emerging nations. Market segmentation highlights the dominance of disposable and powered surgical stapling devices due to convenience and enhanced functionality. North America leads, driven by innovative tech
  Nov 21, 2025
• 2 Fantastic Dividend Stocks to Buy and Hold Forever
  These companies have been raising their payouts for a combined 101 consecutive years.
  Nov 21, 2025
• Medtronic price target raised to $118 from $111 at RBC Capital
  RBC Capital raised the firm’s price target on Medtronic (MDT) to $118 from $111 and keeps an Outperform rating on the shares. The company delivered a 1.0% beat on sales and 3.8% on EPS in Q2, driven by accelerating cardiovascular performance, the analyst tells investors in a research note. RBC further cites Medtronic expecting similar growth in Q3 and to exit the FY at 6%, noting that its thesis of growth acceleration is playing out. Published first on TheFly – the ultimate source for real-time,
  Nov 20, 2025
• Diabetes Care Devices Markets, 2023-2024 & 2025-2033 with Abbott, Dexcom, Medtronic, Roche, Ascensia, LifeScan, Novo Nordisk, Eli Lilly, and Sanofi Leading
  The diabetes care devices market is driven by rising diabetes cases and demand for advanced monitoring and insulin solutions. Opportunities lie in emerging markets where lifestyle shifts increase diabetes rates, along with innovations like AI analytics and connected devices accelerating personalized care.Dublin, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Care Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and For
  Nov 20, 2025
• Medtronic Spark Scholarship Launches To Help Students From Low-Income Households Globally Pursue Health Tech Careers
  Medtronic Spark Scholarship provides financial assistance and access to support services for students pursuing health tech and related degrees NORTHAMPTON, MA / ACCESS Newswire / November 20, 2025 / Medtronic, a global leader in healthcare technology, ...
  Nov 20, 2025
• Company News for Nov 19, 2025
  Companies in The News Are: MDT,MGIC,AS,ESLT
  Nov 19, 2025
• Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine?
  Intuitive Surgical's Ion platform represents robust growth potential with strong procedure growth. Clinical trial data demonstrate superiority in diagnostic yield.
  Nov 19, 2025
• DoorDash, Baidu upgraded: Wall Street's top analyst calls
  DoorDash, Baidu upgraded: Wall Street's top analyst calls
  Nov 19, 2025
• BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
  Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.
  Nov 19, 2025
• Medtronic Stock Sees RS Rating Pumps Higher
  Medtronic shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 67 to 82.
  Nov 19, 2025
• Nasdaq Futures Gain With All Eyes on Nvidia Earnings
  December Nasdaq 100 E-Mini futures (NQZ25) are trending up +0.44% this morning, signaling a modest rebound from a bruising stretch of losses, while investors look ahead to an earnings report from AI darling Nvidia.
  Nov 19, 2025
• Medtronic raises FY26 outlook amid cardiac ablation surge
  Medtronic achieved global revenue of almost $9bn in Q2 FY26, with its cardiovascular portfolio contributing $3.44bn.
  Nov 19, 2025
• Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
  Medtronic is on track to advance in 2026 and could rise by 20% to 30% before year-end. Analysts and institutions are accumulating in 2025.
  Nov 19, 2025
• Here Are Wednesday’s Top Wall Street Analyst Research Calls: DoorDash, Freeport-McMoRan, GitLab, Home Depot, Medtronic, Molson-Coors, and More
  Pre-Market Stock Futures: Futures are trading higher this morning, as all the major indices once again closed lower on Tuesday, marking the fourth straight day of losses. The Dow Jones Industrials closed down 1.07% at 46,091, while the S&P 500 was last seen at 6617, down 0.83%. The NASDAQ, which has been hit the hardest ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: DoorDash, Freeport-McMoRan, GitLab, Home Depot, Medtronic, Molson-Coors, and More
  Nov 19, 2025
• Medtronic PLC (MDT) Q2 2026 Earnings Call Highlights: Strong Revenue and EPS Growth Propel ...
  Medtronic PLC (MDT) surpasses expectations with robust growth in cardiac ablation and raises full-year guidance, despite challenges in the cryo business and tariffs.
  Nov 18, 2025
• US Equity Indexes Off Session Lows in Midday Trading
  US equity indexes declined in midday trading on Tuesday, but were off their respective session lows.
  Nov 18, 2025
• US Equity Markets Close Lower as Consumer Discretionary, Tech Sectors Slump
  US equity indexes closed lower Tuesday as consumer discretionary and technology sectors slumped.
  Nov 18, 2025
• Sector Update: Health Care Stocks Rise Late Afternoon
  Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Heal
  Nov 18, 2025
• Google unveils Gemini 3, Klarna & Medtronic stocks react to earnings
  Julie Hyman kicks off Yahoo Finance's Market Minute, taking a look at three of the trending stories on Wall Street, including Alphabet's (GOOG, GOOGL) new Gemini 3 AI model, Klarna's (KLAR) first earnings release since going public, and Medtronic's (MDT) earnings beat. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
  Nov 18, 2025
• Equity Markets Fall Intraday as Big Tech Weighs
  US benchmark equity indexes were lower intraday, weighed down by technology giants Microsoft (MSFT)
  Nov 18, 2025
• Medtronic (MDT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
  The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
  Nov 18, 2025
• Wall Street Eyes Nvidia Earnings, Delayed Jobs Report as US Equity Futures Decline Pre-Bell
  US equity futures were down ahead of Tuesday's opening bell as traders turned their focus to Nvidia'
  Nov 18, 2025
• Equities Hit Lowest Since October Amid Tech Selloff
  Wall Street's major equity benchmarks on Tuesday slumped to their lowest levels since October as maj
  Nov 18, 2025
• Medtronic (MDT) Q2 Earnings and Revenues Top Estimates
  Medtronic (MDT) delivered earnings and revenue surprises of +3.82% and +1.11%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 18, 2025
• Medtronic Lifts Full-Year Guidance as Second-Quarter Results Top Views
  Medtronic (MDT) raised its full-year outlook on Tuesday as the medical device maker logged stronger-
  Nov 18, 2025
• Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs
  MDT posts Q2 earnings and revenue beat, powered by strong Cardiovascular growth and a raised 2026 outlook that lifts its shares.
  Nov 18, 2025
• Home Depot earnings, Fed, homebuilder confidence: What to Watch
  Market Domination Overtime host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, November 18, including quarterly earnings results from companies like Home Depot (HD), Baidu (BIDU, 9888.HK), and Klarna (KLAR); the latest Homebuilder Confidence Index reading; and commentary from Federal Reserve governor Michael Barr. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.
  Nov 18, 2025
• Posthaste: Why Canadian home prices may not have hit bottom yet
  October brings 'tentative reprieve' to price corrections
  Nov 18, 2025
• Medtronic Breaks Out On Another 'Clean Beat' And 300% Growth For One Segment
  Medtronic stock jumped and broke out Tuesday on a "clean beat" driven mainly by its pulsed field ablation technology.
  Nov 18, 2025
• Stocks to Watch Tuesday Recap: Home Depot, Medtronic, Axalta
  ↘️ Home Depot (HD): The big-box retailer cut its annual outlook as the home-improvement downturn continues. The stock closed down more than 6%, its biggest daily decline since 2023. Shares were up slightly after hours.
  Nov 18, 2025
• These Stocks g the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More
  Nvidia and Microsoft unveil a massive AI partnership with Anthropic, Home Depot reduces its full-year sales outlook, and Cloudflare reports widespread outages.
  Nov 18, 2025
• Medtronic Lifts Outlook as Quarterly Profit, Sales Rise
  Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.
  Nov 18, 2025
• Top Stock Movers Now: Home Depot, Cloudflare, Nvidia, and More
  Major U.S. equities indexes extended their slide Tuesday afternoon, amid worries about an AI bubble.
  Nov 18, 2025
• Medtronic Stock Rises After Earnings. What Caught Investors’ Attention.
  Medtronic shares took off after the company posted better financial results than expected, boosted by what management called a “robust” volume of medical procedures. Medtronic sells surgical tools, plus medical devices that treat heart conditions, diabetes, and a range of other conditions, so it benefits when hospitals do more medical procedures. Investors have closely tracked volumes at Medtronic and its peers since the pandemic, which led to delays in many nonessential surgeries.
  Nov 18, 2025
• S&P 500 Gains and Losses Today: Home Depot Slumps as Earnings Disappoint; Medtronic Stock Jumps
  A home improvement retailer faced pressure on Tuesday, Nov. 18, 2025, as housing market headwinds weighed on earnings, while a medical device maker benefitted from strong demand.
  Nov 18, 2025
• Top Analyst Reports for Oracle, Costco & Cisco
  New analyst reports spotlight Oracle's cloud momentum, strategic partnerships and expected fiscal 2026 sales growth.
  Nov 17, 2025
• Internet Of Medical Things (IoMT) Global Market Opportunities and Strategies Report 2025-2034: Top 10 Players Hold 41.94% of 2024 Market, Led by Medtronic at 10.73% Share
  Top market opportunities in the IoMT sector include the rapid growth of wearable devices, real-time monitoring, and the patient end-user segment. Fastest growth is expected in the Asia Pacific and South America regions. Companies should focus on non-invasive monitoring solutions, strategic partnerships, and educating end-users to capitalize on these trends. Global Internet Of Medical Things (IoMT) Market Global Internet Of Medical Things (IoMT) Market Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Th
  Nov 17, 2025
• 2 Giant Healthcare Stocks to Buy Hand Over Fist in November
  Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive healthcare investments in November.
  Nov 17, 2025
• Option Volatility and Earnings Report for November 17 - 21
  It’s a big week for earnings this week with Nvidia and some key retail names taking center stage. This week we have Nvidia, Home Depot, Walmart, Target, Lowes, Palo Alto Networks, Medtronic and Pdd Holdings all reporting.
  Nov 17, 2025
• Nvidia Earnings, Jobs Report, Fed Minutes: What to Watch This Week
  Investors can look forward to the restart of official economic data, starting with the September jobs report. A heavy dose of earnings is on the way too, including results from Nvidia, Home Depot and Walmart.
  Nov 17, 2025
• My 3 Favorite Stocks to Buy Right Now
  I'm a big fan of reliable dividend payers, and a few of the most reliable ones are attractively priced right now.
  Nov 16, 2025
• Trick week for stocks
  Stocks face potentially a volatile week. Not just from the earnings that are due from the likes of Nvidia, Walmart, Home Depot, Lowe's and Target. There's also a bit of unease settling over markets coming from crypto land, where prices for bitcoin, ethereum and other crypto currencies have slumped ...
  Nov 16, 2025
• Nvidia, Walmart earnings, and the return of jobs numbers: What to watch this week
  The final full week of trading in November will bring investors key results from the biggest AI and retail names in the market.
  Nov 16, 2025
• Nvidia earnings, FOMC minutes, Sept. jobs report: What to Watch
  Market Domination Overtime host Myles Udland previews several of the biggest stories to come throughout next week, including quarterly earnings results from major companies like Nvidia (NVDA), Home Depot (HD), Target (TGT), and Walmart (WMT); the latest round of commentary from top Federal Reserve officials alongside the minutes from the central bank's October FOMC meeting; and the release of the long-awaited September jobs report scheduled for Thursday, November 20. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.
  Nov 15, 2025
• Could Medtronic’s (MDT) EMEA Digital Move Reveal a Broader Shift in Patient Data Strategy?
  On November 12, 2025, Minze Health announced a three-year agreement with Medtronic to commercialize the Minze Diary Pod across the EMEA region for patients with overactive bladder symptoms using Medtronic’s InterStim system. This collaboration adds a digital health solution to Medtronic’s SNM therapy pathway, aiming to improve patient data collection and clinical decision-making in urinary care. We’ll examine how integrating an automated bladder diary could influence Medtronic’s positioning...
  Nov 14, 2025
• Nvidia, Walmart Earnings, Jobs Report: What to Watch Next Week
  With the government shutdown over, investors can look forward to the restart of jobs and inflation data, starting with the September jobs report. In the meantime, a heavy dose of earnings are on the way, including results from AI giant Nvidia and retailers Home Depot and Walmart.
  Nov 14, 2025
• Stay Ahead of the Game With Medtronic (MDT) Q2 Earnings: Wall Street's Insights on Key Metrics
  Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2025.
  Nov 13, 2025
• The Oncology Institute, Inc. (TOI) Reports Q3 Loss, Beats Revenue Estimates
  The Oncology Institute (TOI) delivered earnings and revenue surprises of -16.67% and +11.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 13, 2025
• J&J's MedTech Unit Sales Improve: Will the Momentum Last?
  J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.
  Nov 12, 2025
• OnPoint Surgical, Inc. Appoints Jeremy Laynor as Chief Commercial Officer to Accelerate Global Growth
  OnPoint Surgical, Inc., a leader in Augmented Reality (AR) and Artificial Intelligence (AI) guidance for spinal interventions, today announced the appointment of Jeremy Laynor as Chief Commercial Officer (CCO).
  Nov 12, 2025
• MDT Q2 Earnings Preview: Cardiovascular Unit Likely to Boost Growth
  Medtronic's Q2 results may see a lift from solid Cardiovascular momentum and strong Diabetes segment growth.
  Nov 12, 2025
• Minze Health Announces Collaboration with Medtronic to Support Patients with Overactive Bladder in EMEA
  ANTWERP, Belgium, November 12, 2025--Minze Health partners with Medtronic to integrate its automated bladder diary, Minze Diary Pod, into Sacral Neuromodulation care for OAB patients.
  Nov 12, 2025
• Diabetic Foot Ulcer Treatment Market Trends and Forecasts, 2020-2024 & 2025-2030 Featuring 3M, Medtronic, ConvaTec, Coloplast, Smith & Nephew, B Braun, Medline, Organogenesis, Molnlycke, Acelity
  The Diabetic Foot Ulcer Treatment Market offers growth opportunities due to rising diabetes prevalence, demand for cost-effective, painless treatments, and increased focus on advanced wound care and telemedicine. The expanding elderly population and obesity rates further drive market demand, while digital health solutions enhance access and outcomes. Diabetic Foot Ulcer Treatment Market Diabetic Foot Ulcer Treatment Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Foot Ulcer Treatm
  Nov 11, 2025
• Medtronic (MDT): Assessing Valuation Following Recent Modest Share Price Gain
  Medtronic (MDT) shares edged slightly higher this week, with the stock gaining about 0.5% in the last trading session. Investors seem to be keeping an eye on the company’s performance as broader healthcare trends unfold. See our latest analysis for Medtronic. Medtronic’s 15.5% share price return so far this year reflects cautious optimism around its progress, even as recent 30-day softness has tempered momentum. The company’s one-year total shareholder return of 8.4% highlights steady but...
  Nov 11, 2025
• Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M
  The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising cancer cases and demand for effective chronic disease treatments. Emerging economies show potential for growth, propelled by an increasing need for tissue engineering and organ transplantation solutions. Regenerative Medicine Market Regenerative Medicine Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market - Global Industry Size, Share, Trends, Opp
  Nov 11, 2025
• Empowering Employees To Lead Environmental Change
  Together, we can make a positive impact on the environment through advocacy, education, and connection NORTHAMPTON, MA / ACCESS Newswire / November 11, 2025 / We're focused on building a more sustainable future. To help with this, a grassroots group ...
  Nov 11, 2025
• Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know.
  Medtronic has its own surgical robot and it is working to become a more profitable business.
  Nov 11, 2025
• Ken Washington appointed to TE Connectivity board of directors
  The board of directors of TE Connectivity plc (NYSE: TEL), a world leader in connectors and sensors, has appointed Ken Washington to the board, effective November 17, 2025.
  Nov 10, 2025

MDT Reviews

• BuyLowBro

  Dec 29, 2025

  $MDT They’re in the business of making people feel better. Kind of like a good pizza, but for your insides! Who wouldn’t want a slice of that?

  Buy

• YOLOTrader

  Dec 28, 2025

  $MDT Healthcare is cool, but this company makes it cooler than a superhero movie—saving lives and still being stylish!

  Buy

• LiquidityLord

  Dec 27, 2025

  $MDT This healthcare giant continues to lead in medical technology, consistently delivering groundbreaking devices and therapies. Their focus on enhancing patient outcomes and expanding global access to healthcare solutions bodes well for future success.

  Buy

• FiscalFury

  Dec 27, 2025

  $MDT Investing here feels like buying a one-way ticket on a roller coaster—hold on tight and enjoy the ups and downs!

  Buy

• VolatileViking

  Dec 27, 2025

  $MDT When your medical gadget could double as a sci-fi movie prop, you know you're in for a wild ride!

  Buy

• CashOverload

  Dec 26, 2025

  $MDT If only innovation matched the stock price's fall.

  Sell

• BearMarketSurvivor

  Dec 26, 2025

  $MDT Health tech keepin' it fresh, always in demand, you know what’s up!

  Buy

• DividendVandal

  Dec 25, 2025

  $MDT As a global leader in medical technology, this company is known for its dedication to improving patient outcomes through innovative solutions. Its consistent investment in research and development underscores its commitment to advancing healthcare.

  Buy

• TraderFury

  Dec 25, 2025

  $MDT Navigating the complex healthcare landscape while ensuring patient safety is no small feat. Any miscalculation could lead to significant repercussions, both financially and ethically!

  Sell

• DividendDemon

  Dec 25, 2025

  $MDT This stock is like a medical professional – it knows how to fix things and make you feel better, even if your portfolio is a bit sick!

  Buy

• CashOverload

  Dec 24, 2025

  $MDT Big promises with the usual questionable delivery.

  Sell

• MarketPulseX

  Dec 24, 2025

  $MDT With a strong pipeline of innovative medical solutions, this company is at the forefront of enhancing patient care and outcomes. Its commitment to research and development showcases its ambition in the healthcare ecosystem.

  Buy

• VolatilityViper

  Dec 23, 2025

  $MDT Still pretending to innovate while the competition leaves them in the dust.

  Sell

• DividendJunkie

  Dec 23, 2025

  $MDT You’d probably trust a faulty toaster more.

  Sell

• RiskDriver

  Dec 23, 2025

  $MDT As a key player in the medical technology sector, this firm consistently pushes the boundaries of innovation. Its portfolio of life-saving devices and therapies reflects a strong commitment to improving patient outcomes.

  Buy

• MissionOverlord

  Dec 23, 2025

  $MDT Health tech reppin’ hard, got the moves for the long haul!

  Buy

• TheRiskDealer

  Dec 22, 2025

  $MDT The healthcare sector is a wild ride lately! With tech innovations and regulatory changes colliding, it's a frantic scramble to keep ahead. Will they make the right moves in this unpredictable environment?

  Buy

• DigitalDividend

  Dec 22, 2025

  $MDT This medtech company is like the doc who gives you a lollipop after a shot—totally sweet, even if the other part stings a bit!

  Buy

• TradeNova

  Dec 22, 2025

  $MDT Solid fundamentals, it’s holding down the block!

  Buy

• MarketMatrix

  Dec 22, 2025

  $MDT This stock might just keep you alive longer—talk about a lifeline in the market!

  Buy

• MoneyMage

  Dec 22, 2025

  $MDT Innovative? More like reruns of bad ideas.

  Sell

• IndexPredator

  Dec 22, 2025

  $MDT With increasing scrutiny on healthcare products, this giant is grappling with scrutiny that could sink its reputation. Are they prepared to weather the storm or will they crumble under pressure?

  Sell

• MarketGlitch

  Dec 20, 2025

  $MDT With healthcare in flux, every news cycle feels like a heart-stopping drama. Will innovation lead the way or are we just running in circles? Brace yourself for the next episode!

  Sell

• EquityAssault

  Dec 20, 2025

  $MDT Stuck in a hospital gown, waiting for a miracle.

  Sell

• StonkViking

  Dec 20, 2025

  $MDT Health tech givin' us life, stayin' ahead of the game!

  Buy

• CashMeOutside

  Dec 20, 2025

  $MDT Healin' the world one gadget at a time, straight up legendary!

  Buy

• PortfolioFreak

  Dec 20, 2025

  $MDT In healthcare, every innovation can feel like a race against time. If they can’t keep up with the latest advancements, they risk losing credibility and market position!

  Sell

• MarginLogic

  Dec 20, 2025

  $MDT This leader in medical technology consistently develops innovative solutions that improve patient outcomes. Its commitment to research and development keeps it at the cutting edge of the healthcare sector.

  Buy

• MemeInvestor

  Dec 20, 2025

  $MDT This stock is like the ultimate repair kit; it fixes your portfolio faster than you can say 'oops, I did it again!'

  Buy

• RiskProtocol

  Dec 19, 2025

  $MDT The pressure is mounting as competitors close in. Every move counts, and the stakes have never been higher! Will they adapt fast enough to revolutionize their game?

  Sell

• BullishBard

  Dec 19, 2025

  $MDT Saving lives like a superhero but with better gadgets—move over Batman! Just remember, their gadgets won’t help with your laundry.

  Buy

• OptionOutlaw

  Dec 19, 2025

  $MDT Still riding the coattails of past successes; where’s the spark?

  Sell

• TradeNinja

  Dec 19, 2025

  $MDT Like that one friend who always has the best advice - they're reliable, and you know they have your back!

  Buy

• WallStreetGrim

  Dec 18, 2025

  $MDT This company is at the forefront of innovation in the medical technology sector, consistently delivering cutting-edge solutions that improve patient outcomes. Their robust pipeline and commitment to research and development suggest a promising trajectory in a growing healthcare market.

  Buy

• MarginBeast

  Dec 18, 2025

  $MDT Just more medical mumbo jumbo with high hopes.

  Sell

• CashMeOutside

  Dec 18, 2025

  $MDT Tech finesse in the health lane, always got your back.

  Buy

• StockSpecter

  Dec 18, 2025

  $MDT Health tech? They seem more sick than healthy.

  Sell

• TheTradingVerse

  Dec 17, 2025

  $MDT With a rich history in developing advanced medical technologies, this organization is dedicated to improving patient outcomes. Its recent innovations signal a promising trajectory in the increasingly competitive healthcare sector.

  Buy

• DividendDegen

  Dec 17, 2025

  $MDT They’re patchin' up the health game, keepin' folks on the mend!

  Sell

• PixelBroker

  Dec 17, 2025

  $MDT Like a superhero for your heart! Who knew saving lives could also be this cool?

  Buy

• RiskAssassin

  Dec 15, 2025

  $MDT In the healthcare arena, innovation is key! But as competition heats up, you never know when the next big breakthrough will come or if it will crumble in a heartbeat!

  Buy

• BagholderElite

  Dec 15, 2025

  $MDT Solid player in the game, always coming through when it counts!

  Buy

• MarginBeast

  Dec 15, 2025

  $MDT Trying to fix problems nobody asked them to solve.

  Sell

• PnLPhantom

  Dec 15, 2025

  $MDT In the medical field, the competition is cutthroat! New innovations are popping up left and right, and there's a frantic energy surrounding this one. Will it stay ahead?

  Buy

• WallStreetWraith

  Dec 15, 2025

  $MDT Medtronic? More like Mediocre-tronic.

  Sell

• GainsGoblin

  Dec 14, 2025

  $MDT Healing the game, but can it keep up with the hustle? Gotta think twice.

  Sell

• Stonks4Days

  Dec 14, 2025

  $MDT Upward pressure not slowing down.

  Buy

• AlphaVandal

  Dec 14, 2025

  $MDT Volume confirming bullish breakout potential.

  Buy

• MarginMarauder

  Dec 14, 2025

  $MDT Making hearts and lives better, one device at a time! Talk about having a heart in the right place.

  Buy

• PaperHandsGone

  Dec 14, 2025

  $MDT Solid as a rock, keepin' it steady in the market grind.

  Buy

• FinTechFrost

  Dec 13, 2025

  $MDT This stock is like the cool doctor in town, fixing broken portfolios and making everything feel better!

  Buy

• AlgoAce

  Dec 13, 2025

  $MDT Bulls reinforcing support levels.

  Buy

• CodeAndCapital

  Dec 13, 2025

  $MDT Investing here feels like having a superhero on your side—saving lives and maybe even saving your portfolio too!

  Buy

• TheTradingVerse

  Dec 13, 2025

  $MDT Falling knife scenario forming.

  Sell

• CashCraze

  Dec 13, 2025

  $MDT This global leader in medical technology showcases strong innovation and a robust product pipeline, addressing critical healthcare needs. The emphasis on patient-centric solutions positions it well for continued success.

  Buy

• MarginMythic

  Dec 12, 2025

  $MDT With healthcare under immense scrutiny and innovation at stake, is this giant ready to break barriers, or will it falter against new challengers?

  Buy

• StonkRider

  Dec 12, 2025

  $MDT Bears taking control of the chart.

  Sell

• FiscalRiot

  Dec 12, 2025

  $MDT Strong positive correlation to market uptrend.

  Buy

• ProfitShade

  Dec 12, 2025

  $MDT Clear bullish runway ahead.

  Buy

• WallStreetBandit

  Dec 12, 2025

  $MDT Sustained buy pressure noted.

  Buy

• Stonks4Days

  Dec 12, 2025

  $MDT Playing it safe, looks like they got the streets on lock.

  Sell

• StonkZombie

  Dec 12, 2025

  $MDT Clear bullish runway ahead.

  Buy

• ProfitLancer

  Dec 11, 2025

  $MDT Sure, it's medical, but who’s getting paid?

  Sell

• DigitalDividend

  Dec 11, 2025

  $MDT They're the wizards of the medical world, making boo-boos disappear faster than my homework on a Friday night!

  Buy

• ChartPhantom

  Dec 11, 2025

  $MDT Sharp bounce confirming bullish trend.

  Buy

• YieldWarden

  Dec 11, 2025

  $MDT Risk heavily skewed downward.

  Sell

• ChartPilot

  Dec 11, 2025

  $MDT Bullish breakout imminent.

  Buy

• TickerTyrant

  Dec 11, 2025

  $MDT Pretending to be cutting-edge when they’re just cutting corners.

  Sell

• AlgoAce

  Dec 11, 2025

  $MDT Price holding above key levels.

  Buy

• EquityAssault

  Dec 11, 2025

  $MDT Momentum decay obvious.

  Sell

• BullRunBoi

  Dec 11, 2025

  $MDT Downtrend brutally intact.

  Sell

• ProfitFang

  Dec 11, 2025

  $MDT Bearish catalyst stacking up.

  Sell

• TendieTitan

  Dec 9, 2025

  $MDT Continuation pattern looks healthy.

  Buy

• OptionOutlaw

  Dec 9, 2025

  $MDT A healthcare giant? More like a healthcare giant snail.

  Sell

• ManiaBroker

  Dec 8, 2025

  $MDT Keeping hearts beating – and stock prices lifting! Talk about a healthy investment!

  Buy

• EarningsEcho

  Dec 8, 2025

  $MDT If fixing hearts was an Olympic sport, this company would take home the gold. Seriously, they’re like the fairy godmothers of the medical world!

  Buy

• StonkSlayer

  Dec 7, 2025

  $MDT If reliability were a person, this stock would be your dependable best friend. Always there when you need them, never ghosting!

  Buy

• MemeInvestor

  Dec 6, 2025

  $MDT This firm is like that friend who always brings the best snacks to the party—can't argue with results or results on a chart!

  Buy

• CapitalHex

  Dec 6, 2025

  $MDT With a strong portfolio of medical devices and a commitment to innovation, this company is well-positioned to address key healthcare challenges. Its focus on improving patient outcomes suggests a sustainable competitive edge.

  Buy

• BearBreaker

  Dec 4, 2025

  $MDT A medical leader lost in a sea of mediocrity.

  Sell

• GainVector

  Dec 4, 2025

  $MDT This established medical technology firm continues to lead the way in developing transformative healthcare solutions. Its strong pipeline of new products and commitment to innovation highlight its potential for long-term growth in the evolving healthcare landscape.

  Buy

• ProfitFang

  Dec 4, 2025

  $MDT Bullish breakout imminent.

  Buy

• QuantKnight

  Dec 3, 2025

  $MDT In a world where innovation in medical technology is crucial, this company is under immense pressure to lead the charge. Will they rise to the occasion, or is it time to reassess?

  Buy

• BearishBoi

  Dec 3, 2025

  $MDT If health gadgets were the latest fashion trend, this company would be the runway superstar—watch out for those health goals in style!

  Buy

• DiamondHands

  Dec 2, 2025

  $MDT This company is like the doctor you want on your team—always in the know and ready to fix your tech problems!

  Buy

• ProfitShade

  Dec 2, 2025

  $MDT This crew knows how to keep hearts pumpin', solid in the game!

  Buy

• ProfitVandal

  Dec 2, 2025

  $MDT This one's like that friend who always bails on plans.

  Sell

• TradeNinja

  Dec 1, 2025

  $MDT This company is basically the superhero of healthcare—saving lives one gadget at a time! Just don’t ask for a cape.

  Buy

• BearHunter

  Dec 1, 2025

  $MDT This company’s got more fixes than a teen’s prom outfit—always ready to patch things up and make ‘em good as new!

  Sell

• FiscalBinary

  Dec 1, 2025

  $MDT It’s a nail-biter! With so many innovations and regulatory hurdles, the stakes are high. It’s either going to transform healthcare or become another cautionary tale!

  Buy

• BearHunter

  Dec 1, 2025

  $MDT If this stock were a video game, it’d be a healer—always fixing up the competition while taking all the glory!

  Buy

• TrendStalker

  Dec 1, 2025

  $MDT Maybe they should focus on fixing their own mess first.

  Sell

• CapitalCrusher

  Nov 30, 2025

  $MDT Imagine a superhero in a lab coat, saving lives one gadget at a time. Definitely makes you think twice about your next doctor's visit!

  Buy

• GainSurge

  Nov 30, 2025

  $MDT In the health tech arena, innovation is crucial, but the pressure to deliver is overwhelming. Stakeholders are on the edge, anxiously awaiting developments that could make or break their trust!

  Buy

• YieldHunter

  Nov 30, 2025

  $MDT This leader in medical technology is well-positioned within a growing sector, with a portfolio that addresses critical healthcare needs. Their continuous innovation and strong pipeline could drive substantial long-term growth.

  Buy

• ChartNomad

  Nov 29, 2025

  $MDT In the fast-paced world of medical devices, this player's next steps are crucial. The spotlight is on them, and one misstep could spell disaster—how do they keep their balance?

  Buy

• ShortKingston

  Nov 29, 2025

  $MDT Think of it as the dependable friend who always remembers your birthday but forgets to bring a cake. You still love them, though!

  Buy

• OptionOverlord

  Nov 29, 2025

  $MDT This stock is like the superhero of the medical world—saving the day one gadget at a time!

  Buy

• PnLPhantom

  Nov 28, 2025

  $MDT With healthcare constantly evolving, this company is on a rollercoaster ride! Innovation is key, but the competition is fierce. One misstep could lead to major repercussions!

  Sell

• RiskVandal

  Nov 28, 2025

  $MDT This one's about as exciting as watching paint dry.

  Sell

• AlphaRogue

  Nov 27, 2025

  $MDT This stock is like a superhero in a lab coat, saving lives one invention at a time. Definitely cool enough to hang with the popular kids!

  Buy

• VolatilityViper

  Nov 27, 2025

  $MDT Still waiting for innovation? Spoiler: it's not coming.

  Sell

• TheChartCode

  Nov 27, 2025

  $MDT This company’s like your well-meaning friend reminding you to take your vitamins—keeping everyone in tip-top shape!

  Buy

• EquityAssault

  Nov 26, 2025

  $MDT This giant is running on fumes.

  Sell

• WallStreetHex

  Nov 26, 2025

  $MDT This established leader in the medical technology space continues to pioneer innovative solutions that improve patient care. Their solid financials and commitment to R&D suggest a positive trajectory moving forward.

  Buy

• BullishCraze

  Nov 25, 2025

  $MDT This well-established firm is known for its commitment to advancing medical technology. With a diverse product portfolio and a focus on innovation, it appears well-equipped to navigate the evolving healthcare landscape.

  Buy

• TradeBlitz

  Nov 24, 2025

  $MDT This one feels like that trusty old bike—you know it’ll get you places, even if it’s not the flashiest ride around!

  Buy

• GammaSlayer

  Nov 24, 2025

  $MDT At this point, it’s more about survival than innovation.

  Sell

• BullRaid

  Nov 24, 2025

  $MDT Spend more on marketing than actual innovation, huh?

  Sell

• BullRunBoss

  Nov 24, 2025

  $MDT With gadgets that even Iron Man would envy, this company is all about making life easier—just don’t let the robots take over, okay?

  Buy

• TheQuantEdge

  Nov 23, 2025

  $MDT This stock is at the forefront of innovation, but with regulatory hurdles looming, it feels like a race against time. The adrenaline is pumping; can it keep its lead?

  Buy

• CashMeOutside

  Nov 23, 2025

  $MDT In the game of healing, they’re playing to win, for real.

  Buy

• IndexPredator

  Nov 23, 2025

  $MDT With healthcare demands constantly evolving, this company is in a relentless chase to innovate. High stakes are involved, and the burden of expectations is heavier than ever.

  Buy

• TradePulse

  Nov 23, 2025

  $MDT With all the buzz around innovative medical devices, one can’t shake the feeling that there’s a tidal wave of potential waiting to be surfed! Are you ready to catch it or let it pass you by?

  Buy

• StonkDestroyer

  Nov 22, 2025

  $MDT A medical giant still playing catch-up with the competition.

  Sell

• GainMachine

  Nov 22, 2025

  $MDT This stock is like a superhero; it’s here to save the day and make life just a tad bit easier!

  Buy

• BullishShade

  Nov 22, 2025

  $MDT This organization is at the forefront of medical innovation, continuously enhancing its product offerings. Their strong pipeline and commitment to research and development may position them as key players in the healthcare sector.

  Buy

• TickerTyrant

  Nov 21, 2025

  $MDT Just because it's big doesn't mean it's good.

  Sell

• GainsOverBrains

  Nov 21, 2025

  $MDT Healing the game with some slick moves, keep an eye on this player!

  Buy

• RiskDriver

  Nov 21, 2025

  $MDT This global leader in medical technology continues to set benchmarks in patient care through innovative solutions. Their ongoing commitment to research and development signifies a strong future in the healthcare industry.

  Buy

• StockShotz

  Nov 21, 2025

  $MDT They might not have a magic wand, but they sure know how to fix a few hearts—literally and figuratively!

  Buy

• SignalStriker

  Nov 21, 2025

  $MDT Healthcare innovation is relentless, and this company is at the forefront, but market pressures are intense. Can they maintain their edge amidst fierce competition? It’s a nail-biter!

  Buy

• MarketSavage

  Nov 21, 2025

  $MDT If only their products were as reliable as their marketing.

  Sell

• StonkRider

  Nov 20, 2025

  $MDT This organization continues to evolve within the medical technology landscape, leveraging cutting-edge research to enhance patient outcomes and drive operational efficiencies, positioning itself strongly in a competitive market.

  Buy

• StonkSamurai

  Nov 20, 2025

  $MDT Still got the goods, folks are keeping their eyes peeled!

  Buy

• QuantRift

  Nov 20, 2025

  $MDT Known for its advanced medical technologies, this organization consistently delivers impactful healthcare solutions. Their pipeline of innovative products and strong market presence reflects a steady commitment to improving patient outcomes.

  Buy

• OptionSpectre

  Nov 18, 2025

  $MDT When innovation feels more like stagnation.

  Sell

• DigitalDividend

  Nov 17, 2025

  $MDT When you need a friend to fix your heart (or your kitchen sink), this company is always there, toolbox in hand.

  Buy

• BullishSniper

  Nov 16, 2025

  $MDT This company is basically the doctor of the stock world—always there to fix problems and keep things running smoothly!

  Buy

• CapitalHex

  Nov 16, 2025

  $MDT A leader in medical technology, this organization continues to enhance patient care through innovative devices and solutions. Its dedication to improving health outcomes positions it as a critical player in the healthcare landscape.

  Buy

• TheGainReaper

  Nov 15, 2025

  $MDT Reliability? More like a broken promise with every quarter.

  Sell

• StonkSlayer

  Nov 15, 2025

  $MDT Making medical devices that are almost as cool as the latest smartphone—too bad they don’t play Candy Crush!

  Buy

• WallStreetRogue

  Nov 14, 2025

  $MDT A healthcare giant battling the stormy seas of regulatory challenges. Will they navigate through successfully, or is trouble lurking just around the corner?

  Sell

• DividendFrame

  Nov 13, 2025

  $MDT This company is at the forefront of innovative medical technology, consistently pushing boundaries to improve patient outcomes. With a strong pipeline of products and a commitment to research and development, it is well-positioned for future growth in a rapidly evolving healthcare landscape.

  Buy

• MarginBeast

  Nov 13, 2025

  $MDT Health tech that might need a health check itself.

  Sell

• QuantQuest

  Nov 12, 2025

  $MDT This company’s got the heart of a champion! Saving lives and making profits like it’s no big deal!

  Buy

• DividendVortex

  Nov 12, 2025

  $MDT Known for its cutting-edge medical technologies, this healthcare giant is at the forefront of innovation. Its robust pipeline and commitment to improving patient outcomes suggest strong growth prospects in the medical device sector.

  Buy

• CapitalNova

  Nov 11, 2025

  $MDT A leader in medical technology, this company consistently delivers groundbreaking solutions that enhance patient care. Their commitment to innovation and quality makes them a reliable choice in the evolving healthcare landscape.

  Buy

• IndexPredator

  Nov 11, 2025

  $MDT In the healthcare sector, this giant is battling not just competitors, but innovation and regulation too! Will it rise to the occasion or get snagged in red tape? The stakes are sky-high!

  Buy

• ChartPhantom

  Nov 11, 2025

  $MDT They help keep the human body running like a well-oiled machine, which might make them the ultimate wellness coach!

  Buy

• BullishSniper

  Nov 11, 2025

  $MDT This stock is like a trusty first aid kit—always there when you need it, keeping things from getting too messy!

  Buy

• TheQuantEdge

  Nov 10, 2025

  $MDT The healthcare landscape is shifting so fast, it feels like you’re always trying to catch a moving train! Innovations could mean the difference between success and failure in such a crucial sector.

  Sell

• WallStreetWolf

  Nov 9, 2025

  $MDT This stock is like the superhero in the medical world—always saving the day when health crises strike!

  Buy

• TheChartCode

  Nov 9, 2025

  $MDT This company is like the MacGyver of medicine—always ready to fix things with a paperclip and a smile!

  Buy

• ByteBull

  Nov 9, 2025

  $MDT Could this be the superhero of medical devices? If so, I’m ready to don my cape and cheer them on!

  Buy

• TickerTyrant

  Nov 9, 2025

  $MDT Healthcare giant or a crumbling facade? You decide.

  Sell

• ChartCrusher

  Nov 9, 2025

  $MDT Medtech? How noble. Yet, here we are.

  Sell

• StockSpecter

  Nov 8, 2025

  $MDT Medical devices that make you question your sanity.

  Sell

• MarginMyth

  Nov 8, 2025

  $MDT Trying to fix problems while creating new ones. Classic.

  Sell

• CandleCrusher

  Nov 8, 2025

  $MDT Innovation waits for no one in the medical field! If they don’t keep pushing boundaries and adapting, they risk falling behind. The pressure is palpable!

  Buy

• CryptoCobra

  Nov 8, 2025

  $MDT They've got the tools to keep people ticking like a well-oiled machine, but watch out for those pesky side effects—kinda like a wild rollercoaster ride!

  Buy

• StonkKnight

  Nov 8, 2025

  $MDT Holding strong in the game, this player ain't backing down!

  Buy

• StonkRider

  Nov 7, 2025

  $MDT This company stands at the forefront of medical technology, continuously innovating to improve patient outcomes. With a diverse portfolio of products and a strong commitment to research and development, it is well-positioned to navigate the evolving healthcare landscape. Investors may find the focus on expanding global markets and enhancing operational efficiencies particularly promising.

  Buy

• TickerTakedown

  Nov 7, 2025

  $MDT This company is basically the superhero of medical devices. If gadgets could wear capes, this one would be flying high while saving lives!

  Buy

• ShortRaid

  Nov 5, 2025

  $MDT fast vibes range hands it weak on tax tax hedges talking imo wild fast here now earnings range mode sauce patience out nimble clear earnings tight

  Sell

• TheRiskDealer

  Nov 3, 2025

  $MDT Perfect setup for disappointment right here. This move sponsored by caffeine and.

  Sell

• TradeProtocol

  Oct 29, 2025

  $MDT heating strong king humming hurts spike buzzing talking queued tax patience hands theta hands soon talking keeping mode hard bounce money macro passed maybe soon-ish no now

  Buy

• OptionNomad

  Oct 28, 2025

  $MDT Momentum so steady it could teach yoga. Whole market's giving.

  Sell

• GainsGoblin

  Oct 14, 2025

  $MDT Momentum's cooking and I'm loving every second of it. Candle after candle.

  Buy

• MoneyMage

  Oct 14, 2025

  $MDT Someone fed the bulls protein shakes again. Even my risk management is.

  Buy

• QuantSpecter

  Oct 13, 2025

  $MDT than volume patience dying faster my

  Sell

• FUDCrusher

  Oct 13, 2025

  $MDT pumping tape vibes wild today humming patience watching level-to-level it loud noise hands hurts flows bid tax pumping today

  Buy

• HODLWarrior

  Oct 10, 2025

  $MDT Chart looks like my sleep schedule - completely broken. Rally so slow my WiFi timed out.

  Buy

• CashMeOutside

  Oct 9, 2025

  $MDT Energy in this move is contagious - someone call CNBC. Momentum so clean I'd frame this.

  Buy

• MarginLogic

  Oct 8, 2025

  $MDT range heavy now nasty and clean tbh spike energy mode tape fast patience levels range talking watching soon-ish nimble on mooning humming levels heavy patience

  Buy

• TendieTitan

  Oct 7, 2025

  $MDT smart fast heat tight eyes eyes talking level-to-level it soon-ish feels fast fast flows bid talking spike heat

  Buy

• ProfitVortex

  Oct 6, 2025

  $MDT like market regret and should to apologize ugly it's has spoken, investors smells CEO

  Sell

• WallStreetWraith

  Oct 4, 2025

  $MDT crypto winter looks trend's dumpster

  Sell

• OptionRogue

  Oct 4, 2025

  $MDT hard whispers watching clean levels heavy uptrend tight ath tape now tight imo hedges staying heating

  Buy

• TheChartCode

  Oct 1, 2025

  $MDT maybe money it dumping headfake bagholder humming soon soon-ish city keeping flows now hard now sentiment bleeding loud steady it risk theta macro tape tight tape

  Sell

• BagholderElite

  Sep 27, 2025

  $MDT Riding this wave with tears of joy and a side of regret.

  Sell

• WallStreetWraith

  Sep 25, 2025

  $MDT chart hurts eyes this my

  Sell

• RiskAssassin

  Sep 17, 2025

  $MDT on tape hands on watching check heavy trigger feels risk hurts vibes levels imo printing

  Buy

• TheEquityEdge

  Sep 11, 2025

  $MDT I blinked and lost my lunch money. Riding this wave with tears of joy and a.

  Sell

• EarningsSync

  Sep 7, 2025

  $MDT Even my coffee is less jittery than this price action.

  Buy

• BullRunBoi

  Sep 3, 2025

  $MDT beyond trend repair broken

  Sell

• CashOverload

  Sep 2, 2025

  $MDT keeping humming feels maybe ath clear tax feels theta and risk heater no clean heat bounce

  Buy

• BullRunBoss

  Aug 30, 2025

  $MDT soon-ish buzzing steady range soon hands on diamond range talking risk level-to-level spike fast crushing today risk vol king bounce tbh heavy clear heavy bid hands

  Buy

• MarginBeast

  Aug 26, 2025

  $MDT train express pain

  Sell

• OptionCipher

  Aug 19, 2025

  $MDT This chart needs therapy. Honestly, I'm just here for the memes.

  Sell

• TradeTracer

  Aug 19, 2025

  $MDT spoken, express it's train chart my market has hurts ugly eyes this and pain

  Buy

• RiskRanger

  Aug 12, 2025

  $MDT This rally just cured my Monday blues. Someone fed the bulls protein shakes.

  Sell

• AlphaStriker

  Jun 18, 2025

  $MDT cat mess dive wild city clear fast wall watching lows whoa whoa dumping watching

  Sell

• AlphaRift

  Jun 11, 2025

  $MDT tight maybe frankly ath eyes whoa printing bid queued trigger humming imo crushing heating clean printing flows heating trend sentiment

  Buy

• VolatilityNomad

  Jun 9, 2025

  $MDT patience watching whoa hurts clear now earnings today charts range dead bleeding ugly dumping nasty dumping trap diamond whispers

  Sell

• StonkDestroyer

  Apr 24, 2025

  $MDT vibes here earnings crushing check fast theta talking heat now mooning soon smart hard heating trigger level-to-level gains

  Buy

• BullRunBoss

  Mar 24, 2025

  $MDT ouch lower flows charts rough stops lows macro today whispers energy spike

  Sell

• TradingNomad

  Jan 27, 2025

  $MDT ath frankly vibes today no loud loud today and hands steady hands tbh tax bid queued tape go heater

  Buy

• MarginMythic

  Jan 18, 2025

  $MDT dead today buzzing bagholder range theta heavy energy money theta fast bleeding dead

  Sell

• GainVector

  Jan 14, 2025

  $MDT maybe candle rough trigger wick ugly hands feels broken money weak

  Sell

• WallStreetHex

  Dec 16, 2024

  $MDT clear flows passed imo soon-ish mooning watching hands run tape heavy strong bid clear sentiment whispers level-to-level sentiment hedges fire

  Buy

• MarketWolf

  Sep 17, 2024

  $MDT now tbh heating theta gains eyes nimble nimble here keeping loud smooth on imo spicy soon tape earnings rocket

  Buy

• ProfitVandal

  Jul 6, 2024

  $MDT clear dripping momentum money volume eyes money hard oversold energy heavy

  Buy

• DividendVandal

  Feb 28, 2024

  $MDT pumping alpha feels soon macro heat vibes fast fire dripping

  Buy

• TheAlphaDagger

  Feb 18, 2024

  $MDT now heating bull earnings move tax grind bounce vol fire fast flows money today run soon

  Buy

• TradeSaber

  Nov 29, 2023

  $MDT bid grind flows hedges smooth watching tax keeping earnings go spicy soon-ish king bull diamond queued

  Buy